Boise, ID, United States of America

Matthew David King

This inventor holds 1 USPTO granted patent. Top assignee: Boise State University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew David King. Retrieved from https://idiyas.com/inventor/matthew-david-king

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Matthew David King

Introduction

Matthew David King is an accomplished inventor based in Boise, Idaho. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions.

Latest Patents

Matthew holds a patent for "Pharmaceutical compositions comprising oncostatin M (OSM) antagonist derivatives and methods of use." This patent outlines a method for treating cancer or metastasis by administering at least one OSM antagonist to a subject diagnosed with cancer. The administration of OSM antagonists, including small molecule pharmaceuticals, anti-OSM antibodies, anti-OSM aptamers, and OSM mRNA antagonists, has been shown to inhibit or prevent tumor cell detachment, progression, proliferation, and metastasis in various cancer types.

Career Highlights

Matthew is affiliated with Boise State University, where he conducts his research and development work. His dedication to advancing cancer treatment has positioned him as a key figure in the field.

Collaborations

Matthew collaborates with notable colleagues, including Cheryl Jorcyk and Don Warner, who contribute to his research efforts and enhance the impact of his work.

Conclusion

Matthew David King's innovative approach to cancer treatment through his patented methods showcases his commitment to improving patient outcomes. His work continues to pave the way for advancements in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…